Phase I Trial of LMP2 Antigen-specific TCR T-cell Therapy for Recurrent and Metastatic NPC Patients
Clinical trial NCT03925896 · UNKNOWN
Trial details
- NCT number
- NCT03925896
- Sponsor
- Sun Yat-sen University
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-07
- Primary completion
- 2020-08-01
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.